{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:31Z","timestamp":1787020831056,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372275"],"award-info":[{"award-number":["82372275"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Antimalarial resistance, especially artemisinin resistance, in\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      threatens global malaria control. Molecular surveillance of\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      drug resistance is critical for monitoring the efficacy of artemisinin-based combination therapies (ACTs). Current molecular surveillance tools for\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      artemisinin resistance are restricted to predefined polymorphism hotspots in limited loci (\n                      <jats:italic>Pfk13<\/jats:italic>\n                      domain), failing to capture novel mutations in emerging resistance genes (\n                      <jats:italic>Pfcoronin<\/jats:italic>\n                      ,\n                      <jats:italic>Pfubp1<\/jats:italic>\n                      ,\n                      <jats:italic>Pfap2\u03bc<\/jats:italic>\n                      ) or cover complete coding regions. This study addresses this gap by developing an optimized long-amplicon panel for comprehensive, full-gene resistance surveillance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Six genes were selected for the multiplex PCR amplification, including four artemisinin resistance-related markers (\n                      <jats:italic>Pfk13<\/jats:italic>\n                      ,\n                      <jats:italic>Pfcoronin<\/jats:italic>\n                      ,\n                      <jats:italic>Pfap2\u03bc<\/jats:italic>\n                      and\n                      <jats:italic>Pfubp1<\/jats:italic>\n                      ) and two ACTs partner drugs resistance markers (\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      and\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      ). Amplicons were standardized to 2.5\u2009\u00b1\u20090.2 kb using\n                      <jats:italic>multiply<\/jats:italic>\n                      software to minimize amplification bias. The full-length coverage of\n                      <jats:italic>Pfk13<\/jats:italic>\n                      ,\n                      <jats:italic>Pfcoronin<\/jats:italic>\n                      and\n                      <jats:italic>Pfap2\u03bc<\/jats:italic>\n                      was achieved. Primer concentrations and annealing temperatures were iteratively optimized through gel electrophoresis and sequencing validation. Analytical validation was assessed using 11 mock samples (parasitemia ranging from 1% to 0.0001%) and 16 field-collected venous blood (VB) samples. The samples were processed via Illumina paired-end sequencing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The long-amplicon panel was specifically designed to cover the full-length coding region of the\n                      <jats:italic>Pfk13<\/jats:italic>\n                      gene and co-amplify three artemisinin resistance-related molecular markers. It can exhibited species-specific amplification efficiency for\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      targets with undetectable cross-reactivity against non-falciparum\n                      <jats:italic>Plasmodium<\/jats:italic>\n                      species. Analytical sensitivity thresholds were at 50 parasites\/\u03bcL for dried blood spots (DBS) sample and 5 parasites\/\u03bcL for VB sample, with all targets achieving 100% coverage. Notably, DBS samples over 50 p\/\u03bcL required only 0.25GB of sequencing data (mean depth: 55\u2009\u00d7) for complete target coverage, while VB samples above 5 parasites \/\u03bcL required 0.5GB data (mean depth: 33\u2009\u00d7) still keeping over 89% coverage uniformity. The total cost per sample was minimized to $15.60, encompassing PCR amplification, library preparation and sequencing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The new long-amplicon panel improves malaria molecular drug-resistance monitoring by detecting known and emerging mutations across entire genes in a single test. The high sensitivity for ultralow parasitemia samples, coupled with their species specificity and cost-effectiveness, makes it a scalable tool for monitoring multidrug-resistant\n                      <jats:italic>P<\/jats:italic>\n                      .\n                      <jats:italic>falciparum<\/jats:italic>\n                      strains, particularly in resource-limited settings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-025-07058-6","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:46:35Z","timestamp":1761043595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multiplex long-amplicon sequencing for comprehensive molecular surveillance of Plasmodium falciparum resistance to artemisinin and partner drugs in artemisinin-based combination therapies (ACTs)"],"prefix":"10.1186","volume":"18","author":[{"given":"Fei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoding","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaobao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"7058_CR1","doi-asserted-by":"publisher","DOI":"10.30875\/9789287076717","volume-title":"World malaria report 2024: addressing inequity in the global malaria response","author":"World Health O","year":"2024","unstructured":"World Health O. World malaria report 2024: addressing inequity in the global malaria response. Geneva: World Health Organization; 2024."},{"key":"7058_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","volume":"77","author":"F Nosten","year":"2007","unstructured":"Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77:181\u201392.","journal-title":"Am J Trop Med Hyg"},{"key":"7058_CR3","volume-title":"Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019)","author":"WHO","year":"2020","unstructured":"WHO. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019). Geneva: World Health Organization; 2020."},{"key":"7058_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1473-3099(22)00492-3","volume":"23","author":"R Tripura","year":"2023","unstructured":"Tripura R, von Seidlein L, Sovannaroth S, Peto TJ, Callery JJ, Sokha M, et al. Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial. Lancet Infect Dis. 2023;23:81\u201390.","journal-title":"Lancet Infect Dis"},{"key":"7058_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04666-4","volume":"22","author":"F De Haan","year":"2023","unstructured":"De Haan F, Amaratunga C, Thi VAC, Orng LH, Vonglokham M, Quang TN, et al. Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion. Malar J. 2023;22:261.","journal-title":"Malar J"},{"key":"7058_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMc1612765","volume":"376","author":"F Lu","year":"2017","unstructured":"Lu F, Culleton R, Zhang M, Ramaprasad A, von Seidlein L, Zhou H, et al. Emergence of indigenous Artemisinin-resistant Plasmodium falciparum in Africa. N Engl J Med. 2017;376:991\u20133.","journal-title":"N Engl J Med"},{"key":"7058_CR7","doi-asserted-by":"crossref","unstructured":"Group WKG-PS. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis. BMC Med. 2019;17:1","DOI":"10.1186\/s12916-018-1207-3"},{"key":"7058_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009133","volume":"16","author":"O Miotto","year":"2020","unstructured":"Miotto O, Sekihara M, Tachibana SI, Yamauchi M, Pearson RD, Amato R, et al. Emergence of artemisinin-resistant Plasmodium falciparum with kelch13 C580Y mutations on the island of New Guinea. PLoS Pathog. 2020;16:e1009133.","journal-title":"PLoS Pathog"},{"key":"7058_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012013","volume":"20","author":"M Vanhove","year":"2024","unstructured":"Vanhove M, Schwabl P, Clementson C, Early AM, Laws M, Anthony F, et al. Temporal and spatial dynamics of Plasmodium falciparum clonal lineages in Guyana. PLoS Pathog. 2024;20:e1012013.","journal-title":"PLoS Pathog"},{"key":"7058_CR10","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1016\/S2666-5247(21)00249-4","volume":"3","author":"FM Kagoro","year":"2022","unstructured":"Kagoro FM, Barnes KI, Marsh K, Ekapirat N, Mercado CEG, Sinha I, et al. Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis. Lancet Microbe. 2022;3:e184\u201392.","journal-title":"Lancet Microbe"},{"key":"7058_CR11","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","volume":"8","author":"AA Fola","year":"2023","unstructured":"Fola AA, Feleke SM, Mohammed H, Brhane BG, Hennelly CM, Assefa A, et al. Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia. Nat Microbiol. 2023;8:1911\u20139.","journal-title":"Nat Microbiol"},{"key":"7058_CR12","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/S1473-3099(20)30228-0","volume":"20","author":"M Imwong","year":"2020","unstructured":"Imwong M, Dhorda M, Myo Tun K, Thu AM, Phyo AP, Proux S, et al. Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study. Lancet Infect Dis. 2020;20:1470\u201380.","journal-title":"Lancet Infect Dis"},{"key":"7058_CR13","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1038\/s41467-022-33873-x","volume":"13","author":"PK Tumwebaze","year":"2022","unstructured":"Tumwebaze PK, Conrad MD, Okitwi M, Orena S, Byaruhanga O, Katairo T, et al. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat Commun. 2022;13:6353.","journal-title":"Nat Commun"},{"key":"7058_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"7058_CR15","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gn\u00e4dig N, Uhlemann AC, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7:11553.","journal-title":"Nat Commun"},{"key":"7058_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1503-3","volume":"15","author":"SD Otienoburu","year":"2016","unstructured":"Otienoburu SD, Ma\u00efga-Ascofar\u00e9 O, Schramm B, Jullien V, Jones JJ, Zolia YM, et al. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Malar J. 2016;15:452.","journal-title":"Malar J"},{"key":"7058_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-118","volume":"12","author":"G Henriques","year":"2013","unstructured":"Henriques G, Martinelli A, Rodrigues L, Modrzynska K, Fawcett R, Houston DR, et al. Artemisinin resistance in rodent malaria\u2013mutation in the AP2 adaptor \u03bc-chain suggests involvement of endocytosis and membrane protein trafficking. Malar J. 2013;12:118.","journal-title":"Malar J"},{"key":"7058_CR18","doi-asserted-by":"publisher","first-page":"12799","DOI":"10.1073\/pnas.1812317115","volume":"115","author":"AR Demas","year":"2018","unstructured":"Demas AR, Sharma AI, Wong W, Early AM, Redmond S, Bopp S, et al. Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility. Proc Natl Acad Sci U S A. 2018;115:12799\u2013804.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7058_CR19","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/infdis\/jiu358","volume":"210","author":"G Henriques","year":"2014","unstructured":"Henriques G, Hallett RL, Beshir KB, Gadalla NB, Johnson RE, Burrow R, et al. Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. J Infect Dis. 2014;210:2001\u20138.","journal-title":"J Infect Dis"},{"key":"7058_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.01542-19","volume":"64","author":"RC Henrici","year":"2019","unstructured":"Henrici RC, van Schalkwyk DA, Sutherland CJ. Modification of pfap2\u03bc and pfubp1 markedly reduces ring-stage susceptibility of Plasmodium falciparum to artemisinin in Vitro. Antimicrob Agents Chemother. 2019;64:1.","journal-title":"Antimicrob Agents Chemother"},{"key":"7058_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/AAC.02382-16","volume":"61","author":"CJ Sutherland","year":"2017","unstructured":"Sutherland CJ, Lansdell P, Sanders M, Muwanguzi J, van Schalkwyk DA, Kaur H, et al. pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemether-lumefantrine in the United Kingdom. Antimicrob Agents Chemother. 2017;61:3.","journal-title":"Antimicrob Agents Chemother"},{"key":"7058_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009266","volume":"16","author":"AI Sharma","year":"2020","unstructured":"Sharma AI, Shin SH, Bopp S, Volkman SK, Hartl DL, Wirth DF. Genetic background and PfKelch13 affect artemisinin susceptibility of PfCoronin mutants in Plasmodium falciparum. PLoS Genet. 2020;16:e1009266.","journal-title":"PLoS Genet"},{"key":"7058_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijpddr.2020.10.009","volume":"14","author":"ST Windle","year":"2020","unstructured":"Windle ST, Lane KD, Gadalla NB, Liu A, Mu J, Caleon RL, et al. Evidence for linkage of pfmdr1, pfcrt, and pfk13 polymorphisms to lumefantrine and mefloquine susceptibilities in a Plasmodium falciparum cross. Int J Parasitol Drugs Drug Resist. 2020;14:208\u201317.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7058_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"7058_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011436","volume":"19","author":"GM Gomez","year":"2023","unstructured":"Gomez GM, D\u2019Arrigo G, Sanchez CP, Berger F, Wade RC, Lanzer M. Pfcrt mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport. PLoS Pathog. 2023;19:e1011436.","journal-title":"PLoS Pathog"},{"key":"7058_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.actatropica.2011.08.013","volume":"120","author":"OA Folarin","year":"2011","unstructured":"Folarin OA, Bustamante C, Gbotosho GO, Sowunmi A, Zalis MG, Oduola AM, et al. In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria. Acta Trop. 2011;120:224\u201330.","journal-title":"Acta Trop"},{"key":"7058_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064299","volume":"8","author":"FL Eyase","year":"2013","unstructured":"Eyase FL, Akala HM, Ingasia L, Cheruiyot A, Omondi A, Okudo C, et al. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008\u20132011. PLoS ONE. 2013;8:e64299.","journal-title":"PLoS ONE"},{"key":"7058_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15779-8","volume":"11","author":"R Verity","year":"2020","unstructured":"Verity R, Aydemir O, Brazeau NF, Watson OJ, Hathaway NJ, Mwandagalirwa MK, et al. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat Commun. 2020;11:2107.","journal-title":"Nat Commun"},{"key":"7058_CR29","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1038\/s41564-023-01516-6","volume":"8","author":"ST Girgis","year":"2023","unstructured":"Girgis ST, Adika E, Nenyewodey FE, Senoo Jnr DK, Ngoi JM, Bandoh K, et al. Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana. Nat Microbiol. 2023;8:2365\u201377.","journal-title":"Nat Microbiol"},{"key":"7058_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-94716-5","volume":"15","author":"A Aranda-D\u00edaz","year":"2025","unstructured":"Aranda-D\u00edaz A, Neubauer Vickers E, Murie K, Palmer B, Hathaway N, Gerlovina I, et al. Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health. Sci Rep. 2025;15:10737.","journal-title":"Sci Rep"},{"key":"7058_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45688-z","volume":"15","author":"M De Cesare","year":"2024","unstructured":"De Cesare M, Mwenda M, Jeffreys AE, Chirwa J, Drakeley C, Schneider K, et al. Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing. Nat Commun. 2024;15:1413.","journal-title":"Nat Commun"},{"key":"7058_CR32","first-page":"522","volume":"26","author":"F Wang","year":"2014","unstructured":"Wang F, Tian Y, Yang J, Sun FJ, Sun N, Liu BY, et al. Detection of Plasmodium falciparum by using magnetic nanoparticles separation-based quantitative real-time PCR assay. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2014;26:522\u20135.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"key":"7058_CR33","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u201390.","journal-title":"Bioinformatics"},{"key":"7058_CR34","unstructured":"MalariaGEN, Abdel Hamid M, Abdelraheem M, Acheampong D, Ahouidi A, Ali M, et al. Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples [version 1; peer review: 3 approved]. 2023;8 22."},{"key":"7058_CR35","unstructured":"Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. 2013."},{"key":"7058_CR36","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25:2078\u20139.","journal-title":"Bioinformatics"},{"key":"7058_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491\u20138.","journal-title":"Nat Genet"},{"key":"7058_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, le Wang L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6:80\u201392.","journal-title":"Fly (Austin)"},{"key":"7058_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00960-22","volume":"11","author":"JH Kattenberg","year":"2023","unstructured":"Kattenberg JH, Fernandez-Mi\u00f1ope C, van Dijk NJ, Llacsahuanga Allcca L, Guetens P, Valdivia HO, et al. Malaria molecular surveillance in the peruvian amazon with a novel highly multiplexed plasmodium falciparum AmpliSeq Assay. Microbiol Spectr. 2023;11:e0096022.","journal-title":"Microbiol Spectr"},{"key":"7058_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.62997","volume":"10","author":"CG Jacob","year":"2021","unstructured":"Jacob CG, Thuy-Nhien N, Mayxay M, Maude RJ, Quang HH, Hongvanthong B, et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife. 2021;10:1.","journal-title":"Elife"},{"key":"7058_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09474-5","volume":"12","author":"C Kunasol","year":"2022","unstructured":"Kunasol C, Dondorp AM, Batty EM, Nakhonsri V, Sinjanakhom P, Day NPJ, et al. Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers. Sci Rep. 2022;12:5563.","journal-title":"Sci Rep"},{"key":"7058_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-05107-6","volume":"23","author":"KD Avc\u0131","year":"2024","unstructured":"Avc\u0131 KD, Karaku\u015f M, Kart Ya\u015far K. Molecular survey of pfmdr-1, pfcrt, and pfk13 gene mutations among patients returning from Plasmodium falciparum endemic areas to Turkey. Malar J. 2024;23:286.","journal-title":"Malar J"},{"key":"7058_CR43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12936-024-05158-9","volume":"23","author":"BB Agaba","year":"2024","unstructured":"Agaba BB, Travis J, Smith D, Rugera SP, Zalwango MG, Opigo J, et al. Emerging threat of artemisinin partial resistance markers (pfk13 mutations) in Plasmodium falciparum parasite populations in multiple geographical locations in high transmission regions of Uganda. Malar J. 2024;23:330.","journal-title":"Malar J"},{"key":"7058_CR44","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1093\/jac\/dkab264","volume":"76","author":"LC Mathieu","year":"2021","unstructured":"Mathieu LC, Singh P, Monteiro WM, Magris M, Cox H, Lazrek Y, et al. Kelch13 mutations in Plasmodium falciparum and risk of spreading in Amazon basin countries. J Antimicrob Chemother. 2021;76:2854\u201362.","journal-title":"J Antimicrob Chemother"},{"key":"7058_CR45","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac303205m","volume":"85","author":"PA Demirev","year":"2013","unstructured":"Demirev PA. Dried blood spots: analysis and applications. Anal Chem. 2013;85:779\u201389.","journal-title":"Anal Chem"},{"key":"7058_CR46","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1353\/dem.2007.0038","volume":"44","author":"TW McDade","year":"2007","unstructured":"McDade TW, Williams S, Snodgrass JJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography. 2007;44:899\u2013925.","journal-title":"Demography"},{"key":"7058_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13071-018-2762-3","volume":"11","author":"T Adams","year":"2018","unstructured":"Adams T, Ennuson NAA, Quashie NB, Futagbi G, Matrevi S, Hagan OCK, et al. Prevalence of Plasmodium falciparum delayed clearance associated polymorphisms in adaptor protein complex 2 mu subunit (pfap2mu) and ubiquitin specific protease 1 (pfubp1) genes in Ghanaian isolates. Parasit Vectors. 2018;11:175.","journal-title":"Parasit Vectors"},{"key":"7058_CR48","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.aav5427","volume":"365","author":"A Amambua-Ngwa","year":"2019","unstructured":"Amambua-Ngwa A, Amenga-Etego L, Kamau E, Amato R, Ghansah A, Golassa L, et al. Major subpopulations of Plasmodium falciparum in sub-Saharan Africa. Science. 2019;365:813\u20136.","journal-title":"Science"},{"key":"7058_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12879-025-10462-z","volume":"25","author":"V Osoti","year":"2025","unstructured":"Osoti V, Wamae K, Ndwiga L, Gichuki PM, Okoyo C, Kepha S, et al. Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya. BMC Infect Dis. 2025;25:73.","journal-title":"BMC Infect Dis"},{"key":"7058_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2013.10.007","volume":"35","author":"S Krishna","year":"2014","unstructured":"Krishna S, Pulcini S, Moore CM, Teo BH, Staines HM. Pumped up: reflections on PfATP6 as the target for artemisinins. Trends Pharmacol Sci. 2014;35:4\u201311.","journal-title":"Trends Pharmacol Sci"},{"key":"7058_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijpddr.2020.11.006","volume":"15","author":"A Arya","year":"2021","unstructured":"Arya A, Kojom Foko LP, Chaudhry S, Sharma A, Singh V. Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: a systematic review of clinical studies from two malaria endemic regions - India and sub-Saharan Africa. Int J Parasitol Drugs Drug Resist. 2021;15:43\u201356.","journal-title":"Int J Parasitol Drugs Drug Resist"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07058-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-07058-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07058-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:05:25Z","timestamp":1761048325000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-07058-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7058"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-07058-6","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Jiangsu Institute of Parasitic Diseases (approval number JIPD-2024\u2013017) and written informed consent was obtained from each participant and parent or legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}